カテゴリー： LP Information, 世界, 医療/バイオ

世界の薬物・機器コンビネーション製品市場予測 2021年-2026年

【英語タイトル】Global Drug-Device Combination Products Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY8946）・商品コード：LPI21MY8946
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：131
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療装置
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「薬物・機器コンビネーション製品の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、薬剤溶出性ステント、光増感剤、整形外科用製品、輸液ポンプ、創傷治療用製品、吸入器、経皮パッチ、その他など、用途別には、心臓血管、非心臓血管、泌尿器科、骨治療、抗菌治療、癌治療、眼科治療、糖尿病治療などにセグメント区分してまとめました。薬物・機器コンビネーション製品のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・薬物・機器コンビネーション製品の世界市場概要（サマリー）
・薬物・機器コンビネーション製品の企業別販売量・売上
・薬物・機器コンビネーション製品の企業別市場シェア
・薬物・機器コンビネーション製品の世界市場規模 2016年-2021年：種類別（薬剤溶出性ステント、光増感剤、整形外科用製品、輸液ポンプ、創傷治療用製品、吸入器、経皮パッチ、その他）
・薬物・機器コンビネーション製品の世界市場規模 2016年-2021年：用途別（心臓血管、非心臓血管、泌尿器科、骨治療、抗菌治療、癌治療、眼科治療、糖尿病治療）
・薬物・機器コンビネーション製品の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・薬物・機器コンビネーション製品のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・薬物・機器コンビネーション製品のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・薬物・機器コンビネーション製品の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・薬物・機器コンビネーション製品市場の成長要因・課題・動向
・薬物・機器コンビネーション製品の世界市場予測 2021年-2026年
・薬物・機器コンビネーション製品の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・薬物・機器コンビネーション製品のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・薬物・機器コンビネーション製品のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・薬物・機器コンビネーション製品の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・薬物・機器コンビネーション製品の世界市場予測：種類別（薬剤溶出性ステント、光増感剤、整形外科用製品、輸液ポンプ、創傷治療用製品、吸入器、経皮パッチ、その他）
・薬物・機器コンビネーション製品の世界市場予測：用途別（心臓血管、非心臓血管、泌尿器科、骨治療、抗菌治療、癌治療、眼科治療、糖尿病治療）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Drug-Device Combination Products will have significant change from previous year. By the most conservative estimates of global Drug-Device Combination Products market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 74560 million in 2019. Over the next five years the Drug-Device Combination Products market will register a 4.1% CAGR in terms of revenue, the global market size will reach US$ 87420 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Device Combination Products market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Drug Eluting Stents
Photosensitizers
Orthopaedic products
Infusion Pumps
Wound Care Products
Inhalers
Transdermal Patches
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Cardiovascular
Non-Cardiovascular
Urological
Bone Treatment
Antimicrobial treatment
Cancer Treatment
Ophthalmic Treatment
Diabetes Treatment

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Abbott
Boston Scientific
Cook Medical
Medtronic
Smith & Nephew
Abbott
Stryker
Zimmer
Ethicon
C.R. Bard

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug-Device Combination Products Consumption 2016-2026
2.1.2 Drug-Device Combination Products Consumption CAGR by Region
2.2 Drug-Device Combination Products Segment by Type
2.2.1 Drug Eluting Stents
2.2.2 Photosensitizers
2.2.3 Orthopaedic products
2.2.4 Infusion Pumps
2.2.5 Wound Care Products
2.2.6 Inhalers
2.2.7 Transdermal Patches
2.2.8 Others
2.3 Drug-Device Combination Products Sales by Type
2.3.1 Global Drug-Device Combination Products Sales Market Share by Type (2016-2021)
2.3.2 Global Drug-Device Combination Products Revenue and Market Share by Type (2016-2021)
2.3.3 Global Drug-Device Combination Products Sale Price by Type (2016-2021)
2.4 Drug-Device Combination Products Segment by Application
2.4.1 Cardiovascular
2.4.2 Non-Cardiovascular
2.4.3 Urological
2.4.4 Bone Treatment
2.4.5 Antimicrobial treatment
2.4.6 Cancer Treatment
2.4.7 Ophthalmic Treatment
2.4.8 Diabetes Treatment
2.5 Drug-Device Combination Products Sales by Application
2.5.1 Global Drug-Device Combination Products Sale Market Share by Application (2016-2021)
2.5.2 Global Drug-Device Combination Products Revenue and Market Share by Application (2016-2021)
2.5.3 Global Drug-Device Combination Products Sale Price by Application (2016-2021)

3 Global Drug-Device Combination Products by Company
3.1 Global Drug-Device Combination Products Sales Market Share by Company
3.1.1 Global Drug-Device Combination Products Sales by Company (2019-2021)
3.1.2 Global Drug-Device Combination Products Sales Market Share by Company (2019-2021)
3.2 Global Drug-Device Combination Products Revenue Market Share by Company
3.2.1 Global Drug-Device Combination Products Revenue by Company (2019-2021)
3.2.2 Global Drug-Device Combination Products Revenue Market Share by Company (2019-2021)
3.3 Global Drug-Device Combination Products Sale Price by Company
3.4 Global Manufacturers Drug-Device Combination Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-Device Combination Products Product Location Distribution
3.4.2 Players Drug-Device Combination Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Drug-Device Combination Products by Region
4.1 Global Drug-Device Combination Products by Region
4.1.1 Global Drug-Device Combination Products Sales by Region
4.1.2 Global Drug-Device Combination Products Revenue by Region
4.2 Americas Drug-Device Combination Products Sales Growth
4.3 APAC Drug-Device Combination Products Sales Growth
4.4 Europe Drug-Device Combination Products Sales Growth
4.5 Middle East & Africa Drug-Device Combination Products Sales Growth

5 Americas
5.1 Americas Drug-Device Combination Products Sales by Country
5.1.1 Americas Drug-Device Combination Products Sales by Country (2016-2021)
5.1.2 Americas Drug-Device Combination Products Revenue by Country (2016-2021)
5.2 Americas Drug-Device Combination Products Sales by Type
5.3 Americas Drug-Device Combination Products Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Drug-Device Combination Products Sales by Region
6.1.1 APAC Drug-Device Combination Products Sales by Region (2016-2021)
6.1.2 APAC Drug-Device Combination Products Revenue by Region (2016-2021)
6.2 APAC Drug-Device Combination Products Sales by Type
6.3 APAC Drug-Device Combination Products Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Drug-Device Combination Products by Country
7.1.1 Europe Drug-Device Combination Products Sales by Country (2016-2021)
7.1.2 Europe Drug-Device Combination Products Revenue by Country (2016-2021)
7.2 Europe Drug-Device Combination Products Sales by Type
7.3 Europe Drug-Device Combination Products Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Drug-Device Combination Products by Country
8.1.1 Middle East & Africa Drug-Device Combination Products Sales by Country (2016-2021)
8.1.2 Middle East & Africa Drug-Device Combination Products Revenue by Country (2016-2021)
8.2 Middle East & Africa Drug-Device Combination Products Sales by Type
8.3 Middle East & Africa Drug-Device Combination Products Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Drug-Device Combination Products Distributors
10.3 Drug-Device Combination Products Customer

11 Global Drug-Device Combination Products Market Forecast
11.1 Global Drug-Device Combination Products Forecast by Region
11.1.1 Global Drug-Device Combination Products Forecast by Regions (2021-2026)
11.2.2 Global Drug-Device Combination Products Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Drug-Device Combination Products Forecast by Type
11.7 Global Drug-Device Combination Products Forecast by Application

12 Key Players Analysis
12.1 Abbott
12.1.1 Abbott Abbott Company Information
12.1.2 Abbott Drug-Device Combination Products Product Offered
12.1.3 Abbott Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Abbott Main Business Overview
12.1.5 Abbott Latest Developments
12.2 Boston Scientific
12.2.1 Boston Scientific Company Information
12.2.2 Boston Scientific Drug-Device Combination Products Product Offered
12.2.3 Boston Scientific Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Boston Scientific Main Business Overview
12.2.5 Boston Scientific Latest Developments
12.3 Cook Medical
12.3.1 Cook Medical Company Information
12.3.2 Cook Medical Drug-Device Combination Products Product Offered
12.3.3 Cook Medical Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Cook Medical Main Business Overview
12.3.5 Cook Medical Latest Developments
12.4 Medtronic
12.4.1 Medtronic Company Information
12.4.2 Medtronic Drug-Device Combination Products Product Offered
12.4.3 Medtronic Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Medtronic Main Business Overview
12.4.5 Medtronic Latest Developments
12.5 Smith & Nephew
12.5.1 Smith & Nephew Company Information
12.5.2 Smith & Nephew Drug-Device Combination Products Product Offered
12.5.3 Smith & Nephew Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Smith & Nephew Main Business Overview
12.5.5 Smith & Nephew Latest Developments
12.6 Abbott
12.6.1 Abbott Company Information
12.6.2 Abbott Drug-Device Combination Products Product Offered
12.6.3 Abbott Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Abbott Main Business Overview
12.6.5 Abbott Latest Developments
12.7 Stryker
12.7.1 Stryker Company Information
12.7.2 Stryker Drug-Device Combination Products Product Offered
12.7.3 Stryker Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Stryker Main Business Overview
12.7.5 Stryker Latest Developments
12.8 Zimmer
12.8.1 Zimmer Company Information
12.8.2 Zimmer Drug-Device Combination Products Product Offered
12.8.3 Zimmer Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Zimmer Main Business Overview
12.8.5 Zimmer Latest Developments
12.9 Ethicon
12.9.1 Ethicon Company Information
12.9.2 Ethicon Drug-Device Combination Products Product Offered
12.9.3 Ethicon Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Ethicon Main Business Overview
12.9.5 Ethicon Latest Developments
12.10 C.R. Bard
12.10.1 C.R. Bard Company Information
12.10.2 C.R. Bard Drug-Device Combination Products Product Offered
12.10.3 C.R. Bard Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 C.R. Bard Main Business Overview
12.10.5 C.R. Bard Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Drug-Device Combination Products Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Drug Eluting Stents
Table 3. Major Players of Photosensitizers
Table 4. Major Players of Orthopaedic products
Table 5. Major Players of Infusion Pumps
Table 6. Major Players of Wound Care Products
Table 7. Major Players of Inhalers
Table 8. Major Players of Transdermal Patches
Table 9. Major Players of Others
Table 10. Global Drug-Device Combination Products Sales by Type (2016-2021) & (K Units)
Table 11. Global Drug-Device Combination Products Sales Market Share by Type (2016-2021)
Table 12. Global Drug-Device Combination Products Revenue by Type (2016-2021) & ($ million)
Table 13. Global Drug-Device Combination Products Revenue Market Share by Type (2016-2021)
Table 14. Global Drug-Device Combination Products Sale Price by Type (2016-2021)
Table 15. Global Drug-Device Combination Products Sales by Application (2016-2021) & (K Units)
Table 16. Global Drug-Device Combination Products Sales Market Share by Application (2016-2021)
Table 17. Global Drug-Device Combination Products Value by Application (2016-2021)
Table 18. Global Drug-Device Combination Products Revenue Market Share by Application (2016-2021)
Table 19. Global Drug-Device Combination Products Sale Price by Application (2016-2021)
Table 20. Global Drug-Device Combination Products Sales by Company (2019-2021) & (K Units)
Table 21. Global Drug-Device Combination Products Sales Market Share by Company (2019-2021)
Table 22. Global Drug-Device Combination Products Revenue by Company (2019-2021) ($ Millions)
Table 23. Global Drug-Device Combination Products Revenue Market Share by Company (2019-2021)
Table 24. Global Drug-Device Combination Products Sale Price by Company (2019-2021)
Table 25. Key Manufacturers Drug-Device Combination Products Producing Area Distribution and Sales Area
Table 26. Players Drug-Device Combination Products Products Offered
Table 27. Drug-Device Combination Products Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Drug-Device Combination Products Sales by Region (2016-2021) (K Units)
Table 31. Global Drug-Device Combination Products Sales Market Share by Region (2016-2021)
Table 32. Global Drug-Device Combination Products Revenue by Region (2016-2021) & ($ Millions)
Table 33. Global Drug-Device Combination Products Revenue Market Share by Region (2016-2021)
Table 34. Americas Drug-Device Combination Products Sales by Country (2016-2021) & (K Units)
Table 35. Americas Drug-Device Combination Products Sales Market Share by Country (2016-2021)
Table 36. Americas Drug-Device Combination Products Revenue by Country (2016-2021) & ($ Millions)
Table 37. Americas Drug-Device Combination Products Revenue Market Share by Country (2016-2021)
Table 38. Americas Drug-Device Combination Products Sales by Type (2016-2021) & (K Units)
Table 39. Americas Drug-Device Combination Products Sales Market Share by Type (2016-2021)
Table 40. Americas Drug-Device Combination Products Sales by Application (2016-2021) & (K Units)
Table 41. Americas Drug-Device Combination Products Sales Market Share by Application (2016-2021)
Table 42. APAC Drug-Device Combination Products Sales by Region (2016-2021) & (K Units)
Table 43. APAC Drug-Device Combination Products Sales Market Share by Region (2016-2021)
Table 44. APAC Drug-Device Combination Products Revenue by Region (2016-2021) & ($ Millions)
Table 45. APAC Drug-Device Combination Products Revenue Market Share by Region (2016-2021)
Table 46. APAC Drug-Device Combination Products Sales by Type (2016-2021) & (K Units)
Table 47. APAC Drug-Device Combination Products Sales Market Share by Type (2016-2021)
Table 48. APAC Drug-Device Combination Products Sales by Application (2016-2021) & (K Units)
Table 49. APAC Drug-Device Combination Products Sales Market Share by Application (2016-2021)
Table 50. Europe Drug-Device Combination Products Sales by Country (2016-2021) & (K Units)
Table 51. Europe Drug-Device Combination Products Sales Market Share by Country (2016-2021)
Table 52. Europe Drug-Device Combination Products Revenue by Country (2016-2021) & ($ Millions)
Table 53. Europe Drug-Device Combination Products Revenue Market Share by Country (2016-2021)
Table 54. Europe Drug-Device Combination Products Sales by Type (2016-2021) & (K Units)
Table 55. Europe Drug-Device Combination Products Sales Market Share by Type (2016-2021)
Table 56. Europe Drug-Device Combination Products Sales by Application (2016-2021) & (K Units)
Table 57. Europe Drug-Device Combination Products Sales Market Share by Application (2016-2021)
Table 58. Middle East & Africa Drug-Device Combination Products Sales by Country (2016-2021) & (K Units)
Table 59. Middle East & Africa Drug-Device Combination Products Sales Market Share by Country (2016-2021)
Table 60. Middle East & Africa Drug-Device Combination Products Revenue by Country (2016-2021) & ($ Millions)
Table 61. Middle East & Africa Drug-Device Combination Products Revenue Market Share by Country (2016-2021)
Table 62. Middle East & Africa Drug-Device Combination Products Sales by Type (2016-2021) & (K Units)
Table 63. Middle East & Africa Drug-Device Combination Products Sales Market Share by Type (2016-2021)
Table 64. Middle East & Africa Drug-Device Combination Products Sales by Application (2016-2021) & (K Units)
Table 65. Middle East & Africa Drug-Device Combination Products Sales Market Share by Application (2016-2021)
Table 66. Global Drug-Device Combination Products Sales Forecast by Type (2021-2026) & (K Units)
Table 67. Global Drug-Device Combination Products Sales Market Share Forecast by Type (2021-2026)
Table 68. Global Drug-Device Combination Products Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 69. Global Drug-Device Combination Products Revenue Market Share Forecast by Type (2021-2026)
Table 70. Global Drug-Device Combination Products Sales Forecast by Application (2021-2026) & (K Units)
Table 71. Global Drug-Device Combination Products Sales Market Share Forecast by Application (2021-2026)
Table 72. Global Drug-Device Combination Products Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 73. Global Drug-Device Combination Products Revenue Market Share Forecast by Application (2021-2026)
Table 74. Abbott Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 75. Abbott Drug-Device Combination Products Product Offered
Table 76. Abbott Drug-Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 77. Abbott Main Business
Table 78. Abbott Latest Developments
Table 79. Boston Scientific Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 80. Boston Scientific Drug-Device Combination Products Product Offered
Table 81. Boston Scientific Drug-Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 82. Boston Scientific Main Business
Table 83. Boston Scientific Latest Developments
Table 84. Cook Medical Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 85. Cook Medical Drug-Device Combination Products Product Offered
Table 86. Cook Medical Drug-Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 87. Cook Medical Main Business
Table 88. Cook Medical Latest Developments
Table 89. Medtronic Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 90. Medtronic Drug-Device Combination Products Product Offered
Table 91. Medtronic Drug-Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 92. Medtronic Main Business
Table 93. Medtronic Latest Developments
Table 94. Smith & Nephew Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 95. Smith & Nephew Drug-Device Combination Products Product Offered
Table 96. Smith & Nephew Drug-Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 97. Smith & Nephew Main Business
Table 98. Smith & Nephew Latest Developments
Table 99. Abbott Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 100. Abbott Drug-Device Combination Products Product Offered
Table 101. Abbott Drug-Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 102. Abbott Main Business
Table 103. Abbott Latest Developments
Table 104. Stryker Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 105. Stryker Drug-Device Combination Products Product Offered
Table 106. Stryker Drug-Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 107. Stryker Main Business
Table 108. Stryker Latest Developments
Table 109. Zimmer Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 110. Zimmer Drug-Device Combination Products Product Offered
Table 111. Zimmer Drug-Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 112. Zimmer Main Business
Table 113. Zimmer Latest Developments
Table 114. Ethicon Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 115. Ethicon Drug-Device Combination Products Product Offered
Table 116. Ethicon Drug-Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 117. Ethicon Main Business
Table 118. Ethicon Latest Developments
Table 119. C.R. Bard Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 120. C.R. Bard Drug-Device Combination Products Product Offered
Table 121. C.R. Bard Drug-Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 122. C.R. Bard Main Business
Table 123. C.R. Bard Latest Developments
List of Figures
Figure 1. Picture of Drug-Device Combination Products
Figure 2. Drug-Device Combination Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug-Device Combination Products Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Drug-Device Combination Products Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Drug-Device Combination Products Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Drug Eluting Stents
Figure 10. Product Picture of Photosensitizers
Figure 11. Product Picture of Orthopaedic products
Figure 12. Product Picture of Infusion Pumps
Figure 13. Product Picture of Wound Care Products
Figure 14. Product Picture of Inhalers
Figure 15. Product Picture of Transdermal Patches
Figure 16. Product Picture of Others
Figure 17. Global Drug-Device Combination Products Sales Market Share by Type in 2020
Figure 18. Global Drug-Device Combination Products Revenue Market Share by Type (2016-2021)
Figure 19. Drug-Device Combination Products Consumed in Cardiovascular
Figure 20. Global Drug-Device Combination Products Market: Cardiovascular (2016-2021) & (K Units)
Figure 21. Drug-Device Combination Products Consumed in Non-Cardiovascular
Figure 22. Global Drug-Device Combination Products Market: Non-Cardiovascular (2016-2021) & (K Units)
Figure 23. Drug-Device Combination Products Consumed in Urological
Figure 24. Global Drug-Device Combination Products Market: Urological (2016-2021) & (K Units)
Figure 25. Drug-Device Combination Products Consumed in Bone Treatment
Figure 26. Global Drug-Device Combination Products Market: Bone Treatment (2016-2021) & (K Units)
Figure 27. Drug-Device Combination Products Consumed in Antimicrobial treatment
Figure 28. Global Drug-Device Combination Products Market: Antimicrobial treatment (2016-2021) & (K Units)
Figure 29. Drug-Device Combination Products Consumed in Cancer Treatment
Figure 30. Global Drug-Device Combination Products Market: Cancer Treatment (2016-2021) & (K Units)
Figure 31. Drug-Device Combination Products Consumed in Ophthalmic Treatment
Figure 32. Global Drug-Device Combination Products Market: Ophthalmic Treatment (2016-2021) & (K Units)
Figure 33. Drug-Device Combination Products Consumed in Diabetes Treatment
Figure 34. Global Drug-Device Combination Products Market: Diabetes Treatment (2016-2021) & (K Units)
Figure 35. Global Drug-Device Combination Products Sales Market Share by Application (2016-2021)
Figure 36. Global Drug-Device Combination Products Revenue Market Share by Application in 2020
Figure 37. Global Drug-Device Combination Products Revenue Market by Company in 2020 ($ Million)
Figure 38. Global Drug-Device Combination Products Revenue Market Share by Company in 2020
Figure 39. Global Drug-Device Combination Products Sales Market Share by Regions (2016-2021)
Figure 40. Global Drug-Device Combination Products Revenue Market Share by Region in 2020
Figure 41. Americas Drug-Device Combination Products Sales 2016-2021 (K Units)
Figure 42. Americas Drug-Device Combination Products Revenue 2016-2021 ($ Millions)
Figure 43. APAC Drug-Device Combination Products Sales 2016-2021 (K Units)
Figure 44. APAC Drug-Device Combination Products Revenue 2016-2021 ($ Millions)
Figure 45. Europe Drug-Device Combination Products Sales 2016-2021 (K Units)
Figure 46. Europe Drug-Device Combination Products Revenue 2016-2021 ($ Millions)
Figure 47. Middle East & Africa Drug-Device Combination Products Sales 2016-2021 (K Units)
Figure 48. Middle East & Africa Drug-Device Combination Products Revenue 2016-2021 ($ Millions)
Figure 49. Americas Drug-Device Combination Products Sales Market Share by Country in 2020
Figure 50. Americas Drug-Device Combination Products Revenue Market Share by Country in 2020
Figure 51. Americas Drug-Device Combination Products Sales Market Share by Type in 2020
Figure 52. Americas Drug-Device Combination Products Sales Market Share by Application in 2020
Figure 53. United States Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 54. Canada Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 55. Mexico Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 56. Brazil Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 57. APAC Drug-Device Combination Products Sales Market Share by Region in 2020
Figure 58. APAC Drug-Device Combination Products Revenue Market Share by Regions in 2020
Figure 59. APAC Drug-Device Combination Products Sales Market Share by Type in 2020
Figure 60. APAC Drug-Device Combination Products Sales Market Share by Application in 2020
Figure 61. China Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 62. Japan Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 63. Korea Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 64. Southeast Asia Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 65. India Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 66. Australia Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 67. Europe Drug-Device Combination Products Sales Market Share by Country in 2020
Figure 68. Europe Drug-Device Combination Products Revenue Market Share by Country in 2020
Figure 69. Europe Drug-Device Combination Products Sales Market Share by Type in 2020
Figure 70. Europe Drug-Device Combination Products Sales Market Share by Application in 2020
Figure 71. Germany Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 72. France Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 73. UK Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 74. Italy Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 75. Russia Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 76. Middle East & Africa Drug-Device Combination Products Sales Market Share by Country in 2020
Figure 77. Middle East & Africa Drug-Device Combination Products Revenue Market Share by Country in 2020
Figure 78. Middle East & Africa Drug-Device Combination Products Sales Market Share by Type in 2020
Figure 79. Middle East & Africa Drug-Device Combination Products Sales Market Share by Application in 2020
Figure 80. Egypt Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 81. South Africa Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 82. Israel Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 83. Turkey Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 84. GCC Country Drug-Device Combination Products Revenue Growth 2016-2021 ($ Millions)
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles


★調査レポート[世界の薬物・機器コンビネーション製品市場予測 2021年-2026年] (コード：LPI21MY8946)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の薬物・機器コンビネーション製品市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の薬物被覆気管内チューブ市場予測 2021年-2026年
    LPI21MY8944 / LP Information / 2021年5月 / LPインフォメーション社の「薬物被覆気管内チューブの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、抗血栓薬コーティング、抗増殖薬コーティング、その他など、用途別には、BPH、尿管狭窄、前立腺癌、食道狭窄、洞狭窄などにセグメント区分してまとめました。薬物被覆気管内チューブのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・薬物被覆気管内チューブの世界市場概要（サマリー） ・薬物被覆気管内チューブの企業別販売量・売上 ・薬物被覆気管内チューブの企業別市場シェア ・薬物被覆気管内チューブの世界市場規模 2016年-2021年：種類別（抗血栓薬コーティング、抗増殖薬コーティング、その他） ・薬物被覆気管内チューブの世界市場規模 2016年-2021年：用途別（BPH、尿管狭窄、前立腺癌、食道狭窄、洞狭窄） ・薬物被覆気管内チューブの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・薬物被覆気管内チューブのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Drug Coated Endotracheal Tubes will have significant change from previous year. By the most conservative estimates of global Drug Coated Endotracheal Tubes market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Drug Coated Endotracheal Tubes market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Drug Coated Endotracheal Tubes...
  • 世界のてんかん治療薬市場予測 2021年-2026年
    LPI21MY9521 / LP Information / 2021年5月 / LPインフォメーション社の「てんかん治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、第一世代治療薬、第二世代治療薬、第三世代治療薬など、用途別には、病院、研究などにセグメント区分してまとめました。てんかん治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・てんかん治療薬の世界市場概要（サマリー） ・てんかん治療薬の企業別販売量・売上 ・てんかん治療薬の企業別市場シェア ・てんかん治療薬の世界市場規模 2016年-2021年：種類別（第一世代治療薬、第二世代治療薬、第三世代治療薬） ・てんかん治療薬の世界市場規模 2016年-2021年：用途別（病院、研究） ・てんかん治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・てんかん治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Epilepsy Drug will have significant change from previous year. By the most conservative estimates of global Epilepsy Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1799.1 million in 2019. Over the next five years the Epilepsy Drug market will register a 1.5% CAGR in terms of revenue, the global market size will reach US$ 1907.3 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Epilepsy Drug market by product type, application, key manufacturers and...
  • 世界の医療用ワイヤレスデバイス市場予測 2021年-2026年
    LPI21MY9111 / LP Information / 2021年5月 / LPインフォメーション社の「医療用ワイヤレスデバイスの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ウェアラブル、埋め込み可能型など、用途別には、病院、クリニックなどにセグメント区分してまとめました。医療用ワイヤレスデバイスのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・医療用ワイヤレスデバイスの世界市場概要（サマリー） ・医療用ワイヤレスデバイスの企業別販売量・売上 ・医療用ワイヤレスデバイスの企業別市場シェア ・医療用ワイヤレスデバイスの世界市場規模 2016年-2021年：種類別（ウェアラブル、埋め込み可能型） ・医療用ワイヤレスデバイスの世界市場規模 2016年-2021年：用途別（病院、クリニック） ・医療用ワイヤレスデバイスの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・医療用ワイヤレスデバイスのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Medical Wireless Device will have significant change from previous year. By the most conservative estimates of global Medical Wireless Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Medical Wireless Device market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Wireless Device market by product type,...
  • 世界のウェアラブル医療用ワイヤレスデバイス市場予測 2021年-2026年
    LPI21MY9335 / LP Information / 2021年5月 / LPインフォメーション社の「ウェアラブル医療用ワイヤレスデバイスの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、血糖値計、心電図計、パルスオキシメータ、血圧計、その他など、用途別には、病院、診療所などにセグメント区分してまとめました。ウェアラブル医療用ワイヤレスデバイスのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ウェアラブル医療用ワイヤレスデバイスの世界市場概要（サマリー） ・ウェアラブル医療用ワイヤレスデバイスの企業別販売量・売上 ・ウェアラブル医療用ワイヤレスデバイスの企業別市場シェア ・ウェアラブル医療用ワイヤレスデバイスの世界市場規模 2016年-2021年：種類別（血糖値計、心電図計、パルスオキシメータ、血圧計、その他） ・ウェアラブル医療用ワイヤレスデバイスの世界市場規模 2016年-2021年：用途別（病院、診療所） ・ウェアラブル医療用ワイヤレスデバイスの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ウェアラブル医療用ワイヤレスデバイスのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Wearable Medical Wireless Device will have significant change from previous year. By the most conservative estimates of global Wearable Medical Wireless Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Wearable Medical Wireless Device market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Wearable Medical Wireless Device...
  • 世界の薬物被覆気管内チューブ市場予測 2021年-2026年
    LPI21MY8943 / LP Information / 2021年5月 / LPインフォメーション社の「薬物被覆気管内チューブの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、経口・経鼻チューブ、カフ付き・カフなしチューブ、予備成形チューブ、強化チューブ、ダブルルーメン気管支内チューブなど、用途別には、病院、医療センター、その他（クリニック・外来手術センター）などにセグメント区分してまとめました。薬物被覆気管内チューブのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・薬物被覆気管内チューブの世界市場概要（サマリー） ・薬物被覆気管内チューブの企業別販売量・売上 ・薬物被覆気管内チューブの企業別市場シェア ・薬物被覆気管内チューブの世界市場規模 2016年-2021年：種類別（経口・経鼻チューブ、カフ付き・カフなしチューブ、予備成形チューブ、強化チューブ、ダブルルーメン気管支内チューブ） ・薬物被覆気管内チューブの世界市場規模 2016年-2021年：用途別（病院、医療センター、その他（クリニック・外来手術センター）） ・薬物被覆気管内チューブの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・薬物被覆気管内チューブのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Drug Coated Endotracheal Tube will have significant change from previous year. By the most conservative estimates of global Drug Coated Endotracheal Tube market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1584.5 million in 2019. Over the next five years the Drug Coated Endotracheal Tube market will register a 3.7% CAGR in terms of revenue, the global market size will reach US$ 1832.7 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Drug Coated Endotracheal Tube...
  • 世界のコンビネーションプライヤー市場予測 2021年-2026年
    LPI21MY6158 / LP Information / 2021年5月 / LPインフォメーション社の「コンビネーションプライヤーの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、5”、6”、7”、8”など、用途別には、家庭、工業などにセグメント区分してまとめました。コンビネーションプライヤーのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・コンビネーションプライヤーの世界市場概要（サマリー） ・コンビネーションプライヤーの企業別販売量・売上 ・コンビネーションプライヤーの企業別市場シェア ・コンビネーションプライヤーの世界市場規模 2016年-2021年：種類別（5”、6”、7”、8”） ・コンビネーションプライヤーの世界市場規模 2016年-2021年：用途別（家庭、工業） ・コンビネーションプライヤーの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・コンビネーションプライヤーのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Combination Pliers will have significant change from previous year. By the most conservative estimates of global Combination Pliers market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Combination Pliers market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Combination Pliers market by product type, application, key manufacturers and...
  • 世界のゴセレリン薬市場予測 2021年-2026年
    LPI21MY9545 / LP Information / 2021年5月 / LPインフォメーション社の「ゴセレリン薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、3.6mg、10.8mgなど、用途別には、前立腺がん、乳がん、子宮内膜症、その他などにセグメント区分してまとめました。ゴセレリン薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ゴセレリン薬の世界市場概要（サマリー） ・ゴセレリン薬の企業別販売量・売上 ・ゴセレリン薬の企業別市場シェア ・ゴセレリン薬の世界市場規模 2016年-2021年：種類別（3.6mg、10.8mg） ・ゴセレリン薬の世界市場規模 2016年-2021年：用途別（前立腺がん、乳がん、子宮内膜症、その他） ・ゴセレリン薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ゴセレリン薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Goserelin Drug will have significant change from previous year. By the most conservative estimates of global Goserelin Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Goserelin Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Goserelin Drug market by product type, application, key manufacturers and...
  • 世界のハンドヘルド型薬物検出器市場予測 2021年-2026年
    LPI21MY6783 / LP Information / 2021年5月 / LPインフォメーション社の「ハンドヘルド型薬物検出器の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、IR分光計、質量分析（MS）、イオン移動度分光測定（IMS）、ガスクロマトグラフィー、ラマン分光測定など、用途別には、法執行機関、航空、イベントセキュリティ、国境警備、港湾、その他などにセグメント区分してまとめました。ハンドヘルド型薬物検出器のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ハンドヘルド型薬物検出器の世界市場概要（サマリー） ・ハンドヘルド型薬物検出器の企業別販売量・売上 ・ハンドヘルド型薬物検出器の企業別市場シェア ・ハンドヘルド型薬物検出器の世界市場規模 2016年-2021年：種類別（IR分光計、質量分析（MS）、イオン移動度分光測定（IMS）、ガスクロマトグラフィー、ラマン分光測定） ・ハンドヘルド型薬物検出器の世界市場規模 2016年-2021年：用途別（法執行機関、航空、イベントセキュリティ、国境警備、港湾、その他） ・ハンドヘルド型薬物検出器の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ハンドヘルド型薬物検出器のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Handheld Drug Detectors will have significant change from previous year. By the most conservative estimates of global Handheld Drug Detectors market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Handheld Drug Detectors market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Handheld Drug Detectors market by product type,...
  • 世界の吻合補助装置市場予測 2021年-2026年
    LPI21MY8710 / LP Information / 2021年5月 / LPインフォメーション社の「吻合補助装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、再利用可能式、使い捨て式など、用途別には、心臓血管手術、一般手術、婦人科手術、整形手術、眼科手術、その他などにセグメント区分してまとめました。吻合補助装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・吻合補助装置の世界市場概要（サマリー） ・吻合補助装置の企業別販売量・売上 ・吻合補助装置の企業別市場シェア ・吻合補助装置の世界市場規模 2016年-2021年：種類別（再利用可能式、使い捨て式） ・吻合補助装置の世界市場規模 2016年-2021年：用途別（心臓血管手術、一般手術、婦人科手術、整形手術、眼科手術、その他） ・吻合補助装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・吻合補助装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anastomosis Assist Device will have significant change from previous year. By the most conservative estimates of global Anastomosis Assist Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1643.5 million in 2019. Over the next five years the Anastomosis Assist Device market will register a 6.0% CAGR in terms of revenue, the global market size will reach US$ 2072.9 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anastomosis Assist Device market by product type,...
  • 世界の成長ホルモン薬市場予測 2021年-2026年
    LPI21MY9546 / LP Information / 2021年5月 / LPインフォメーション社の「成長ホルモン薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ノルディトロピン、ジェノトロピン、フマトロープ、サイゼン、ニュートロピンなど、用途別には、小売薬局、病院薬局、オンライン薬局などにセグメント区分してまとめました。成長ホルモン薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・成長ホルモン薬の世界市場概要（サマリー） ・成長ホルモン薬の企業別販売量・売上 ・成長ホルモン薬の企業別市場シェア ・成長ホルモン薬の世界市場規模 2016年-2021年：種類別（ノルディトロピン、ジェノトロピン、フマトロープ、サイゼン、ニュートロピン） ・成長ホルモン薬の世界市場規模 2016年-2021年：用途別（小売薬局、病院薬局、オンライン薬局） ・成長ホルモン薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・成長ホルモン薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Growth Hormone Drug will have significant change from previous year. By the most conservative estimates of global Growth Hormone Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Growth Hormone Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Growth Hormone Drug market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆